Today: 30 June 2026
CrowdStrike stock dips as year-end tech pullback drags cybersecurity names
29 December 2025
1 min read

CrowdStrike stock dips as year-end tech pullback drags cybersecurity names

NEW YORK, December 29, 2025, 13:49 ET — Regular session.

  • CrowdStrike down about 1% in afternoon trading.
  • Palo Alto Networks, Fortinet and Zscaler also lower in a softer tape for cybersecurity.
  • Investors eye Fed minutes and jobless claims in a holiday-shortened week with markets shut Thursday.

CrowdStrike Holdings, Inc. shares fell about 1% on Monday, down $4.77 to $476.42 in afternoon trading.

The move put the cybersecurity firm among the decliners as investors pared exposure to technology shares in the final trading week of 2025 after last week’s rally pushed U.S. indexes to record highs, a Reuters report showed.

Trading is expected to stay thin in the holiday-affected week, with U.S. markets closed on Thursday for New Year’s Day. Minutes from the Federal Reserve’s previous meeting and a weekly reading of jobless claims are among the main macro events on the calendar, Reuters reported.

CrowdStrike traded between $474.64 and $483.10 on the session, after opening at $478.68, market data showed.

Other cybersecurity stocks moved in the same direction. Palo Alto Networks fell 0.9%, Fortinet dropped 1.2% and Zscaler slid 1.1%, while SentinelOne added 0.2%.

At 11:13 a.m. ET, the Nasdaq was down 0.6% and the S&P 500 was off 0.4% as heavyweight tech names retreated, Reuters said.

“This is not the beginning of the end of the tech dominance, it’ll turn out to be a buying opportunity,” said Hank Smith, director and head of investment strategy at Haverford Trust. Reuters

CrowdStrike sells cloud-based cybersecurity software that protects endpoints — devices such as laptops and servers — as well as cloud workloads. It competes with firms including Palo Alto Networks and Fortinet.

With few CrowdStrike-specific headlines driving trading on Monday, the stock largely tracked moves in the broader software and security group.

The next focal point is the company’s quarterly report, expected around March 3, 2026, according to data published by MLQ.ai, though the company has not confirmed a date. The site lists an analyst EPS estimate of about $1.10 per share, and investors typically focus on annual recurring revenue (ARR) — a subscription metric that tracks the value of contracted, repeatable revenue — and customer retention.

On charts, the $475 area — near Monday’s intraday low — is an early level traders will watch as the holiday week keeps liquidity thin.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386
Previous Story

Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop